CagriSema Dual-Pathway Metabolic Signaling Compound CagriSema combines two investigational molecules Cagrilintide (amylin analogue) and Semaglutide (GLP-1 receptor agonist), designed to influence key metabolic and appetite-regulating pathways. Current US$ 25.39 Min. order: 1 piece ★★★★★ 4.9 (94 reviews) Sold : Login>>
Cagrilintide Peptide – Research Compound & Study Overview US$ 28.83 Min. order: 1 piece ★★★★★ 5.0 (14 reviews) Sold : Login>>
Does receptor balance matter? – Comparing the efficacies of the dual amylin and calcitonin receptor agonists cagrilintide and KBP-336 on metabolic parameters in preclinical models US$ 27.22 Min. order: 1 piece ★★★★★ 4.4 (124 reviews) Sold : Login>>
Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial US$ 21.66 Min. order: 1 piece ★★★★★ 4.6 (248 reviews) Sold : Login>>
Development of Cagrilintide, a Long-Acting Amylin Analogue US$ 20.01 Min. order: 1 piece ★★★★★ 4.4 (63 reviews) Sold : Login>>